BANK OF AMERICA CORP /DE/ - ACASTI PHARMA INC ownership

ACASTI PHARMA INC's ticker is and the CUSIP is 00430K873. A total of 10 filers reported holding ACASTI PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of ACASTI PHARMA INC
ValueSharesWeighting
Q1 2022$69,000
+165.4%
56,583
+174.4%
0.00%
Q4 2021$26,000
+2500.0%
20,621
+3199.4%
0.00%
Q3 2021$1,0006250.00%
Other shareholders
ACASTI PHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
ROYAL BANK OF CANADA 227$00.00%
UBS Group AG 1,188$1,0000.00%
Koshinski Asset Management, Inc. 2,000$2,440,0000.00%
BANK OF AMERICA CORP /DE/ 56,583$69,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 18,348$22,0000.00%
MORGAN STANLEY 54,464$66,0000.00%
NATIONAL BANK OF CANADA /FI/ 18,418$22,0000.00%
Tower Research Capital LLC (TRC) 612$1,0000.00%
View complete list of ACASTI PHARMA INC shareholders